OBJECTIVE: To determine the association between the apolipoprotein epsilon 4 allele and concussion. We hypothesized that apolipoprotein epsilon 4 carriers may be more likely to sustain a concussion. DESIGN: Prospective cohort study. SETTING: University of Toronto varsity athletics. PARTICIPANTS: Included 318 of 822 collegiate student athletes who participated in University of Toronto varsity sports from September 2002 to April 2006. ASSESSMENT OF RISK FACTORS: The presence of apolipoprotein epsilon 4 was described dichotomously after genotyping blood samples collected from participants. MAIN OUTCOME MEASUREMENTS: Concussions were identified by sport-medicine professionals present on the sidelines using on-field assessment forms. All concussion diagnoses were verified by a sports medicine physician. Survival analysis was used to determine the association between apolipoprotein epsilon 4 and first concussion. RESULTS: The unadjusted hazard ratio for concussion in the apolipoprotein epsilon 4 carriers was 1.18 (95% CI: 0.52, 2.69) compared to noncarriers. Adjustment for sex, weight, height, and team type resulted in a hazard ratio of 1.06 (95% CI: 0.41, 2.72), indicating little effect from confounding factors. CONCLUSIONS: There is no important association between carrying the apolipoprotein epsilon 4 allele and sustaining a concussion. At this time, we do not recommend preseason genetic testing for varsity athletes as a mechanism for targeting prevention strategies.
OBJECTIVE: To determine the association between the apolipoprotein epsilon 4 allele and concussion. We hypothesized that apolipoprotein epsilon 4 carriers may be more likely to sustain a concussion. DESIGN: Prospective cohort study. SETTING: University of Toronto varsity athletics. PARTICIPANTS: Included 318 of 822 collegiate student athletes who participated in University of Toronto varsity sports from September 2002 to April 2006. ASSESSMENT OF RISK FACTORS: The presence of apolipoprotein epsilon 4 was described dichotomously after genotyping blood samples collected from participants. MAIN OUTCOME MEASUREMENTS: Concussions were identified by sport-medicine professionals present on the sidelines using on-field assessment forms. All concussion diagnoses were verified by a sports medicine physician. Survival analysis was used to determine the association between apolipoprotein epsilon 4 and first concussion. RESULTS: The unadjusted hazard ratio for concussion in the apolipoprotein epsilon 4 carriers was 1.18 (95% CI: 0.52, 2.69) compared to noncarriers. Adjustment for sex, weight, height, and team type resulted in a hazard ratio of 1.06 (95% CI: 0.41, 2.72), indicating little effect from confounding factors. CONCLUSIONS: There is no important association between carrying the apolipoprotein epsilon 4 allele and sustaining a concussion. At this time, we do not recommend preseason genetic testing for varsity athletes as a mechanism for targeting prevention strategies.
Authors: Paul McCrory; Willem H Meeuwisse; Mark Aubry; Robert C Cantu; Jiři Dvořák; Ruben J Echemendia; Lars Engebretsen; Karen Johnston; Jeffrey S Kutcher; Martin Raftery; Allen Sills; Brian W Benson; Gavin A Davis; Richard Ellenbogen; Kevin M Guskiewicz; Stanley A Herring; Grant L Iverson; Barry D Jordan; James Kissick; Michael McCrea; Andrew S McIntosh; David Maddocks; Michael Makdissi; Laura Purcell; Margot Putukian; Kathryn Schneider; Charles H Tator; Michael Turner Journal: J Athl Train Date: 2013 Jul-Aug Impact factor: 2.860
Authors: Caroline J Ketcham; Eric Hall; Walter R Bixby; Srikant Vallabhajosula; Stephen E Folger; Matthew C Kostek; Paul C Miller; Kenneth P Barnes; Kirtida Patel Journal: J Vis Exp Date: 2014-12-08 Impact factor: 1.355
Authors: Aaron J Carman; Rennie Ferguson; Robert Cantu; R Dawn Comstock; Penny A Dacks; Steven T DeKosky; Sam Gandy; James Gilbert; Chad Gilliland; Gerard Gioia; Christopher Giza; Michael Greicius; Brian Hainline; Ronald L Hayes; James Hendrix; Barry Jordan; James Kovach; Rachel F Lane; Rebekah Mannix; Thomas Murray; Tad Seifert; Diana W Shineman; Eric Warren; Elisabeth Wilde; Huntington Willard; Howard M Fillit Journal: Nat Rev Neurol Date: 2015-03-17 Impact factor: 42.937
Authors: Mark S Dziemianowicz; Matthew P Kirschen; Bryan A Pukenas; Eric Laudano; Laura J Balcer; Steven L Galetta Journal: Curr Neurol Neurosci Rep Date: 2012-10 Impact factor: 5.081